Sepsis studies need new direction
Authors:
- Jonathan CohenJCJonathan Cohen
- Steven OpalSOSteven Opal
- Thierry CalandraTCThierry Calandra
- 1 July 2012
- journal article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 12 (7) , 503-505
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition*Critical Care Medicine, 2012
- Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteriaIntensive Care Medicine, 2012
- A genomic storm in critically injured humansJournal of Experimental Medicine, 2011
- Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trialCritical Care Medicine, 2009
- Improving clinical trials in the critically ill: Unique challenge—SepsisCritical Care Medicine, 2009
- Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 2004
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001